Cefdinir Capsules 300 mg, Non-fasting

NCT00834535 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Teva Pharmaceuticals USA